Targeted delivery of peptide-conjugated biocompatible gold nanoparticles into cancer cell nucleus

Wei Qian; Taeyjuana Curry; Yong Che; Raoul Kopelman

doi:10.1117/12.2005328

22 February 2013 Targeted delivery of peptide-conjugated biocompatible gold nanoparticles into cancer cell nucleus

Wei Qian, Taeyjuana Curry, Yong Che, Raoul Kopelman

Proceedings Volume 8595, Colloidal Nanocrystals for Biomedical Applications VIII; 85951D (2013) https://doi.org/10.1117/12.2005328
Event: SPIE BiOS, 2013, San Francisco, California, United States

Abstract

Nucleus remains a significant target for nanoparticles with diagnostic and therapeutic applications because both genetic information of the cell and transcription machinery reside there. Novel therapeutic strategies (for example, gene therapy), enabled by safe and efficient delivery of nanoparticles and drug molecules into the nucleus, are heralded by many as the ultimate treatment for severe and intractable diseases. However, most nanomaterials and macromolecules are incapable of reaching the cell nucleus on their own, because of biological barriers carefully honed by evolution including cellular membrane and nuclear envelope. In this paper, we have demonstrated an approach of fabrication of biocompatible gold nanoparticle (Au NP)-based vehicles which can entering into cancer cell nucleus by modifying Au NPs with both PEG 5000 and two different peptides (RGD and nuclear localization signal (NLS) peptide). The Au NPs used were fabricated via femtosecond laser ablation of Au bulk target in deionized water. The Au NPs produced by this method provide chemical free, virgin surface, which allows us to carry out “Sequential Conjugation” to modify their surface with PEG 5000, RGD, and NLS. “Sequential Conjugation” described in this presentation is very critical for the fabrication of Au NP-based vehicles capable of entering into cancer cell nucleus as it enables the engineering and tuning surface chemistries of Au NPs by independently adjusting amounts of PEG and peptides bound onto surface of Au NPs so as to maximize their nuclear targeting performance and biocompatibility regarding the cell line of interest. Both optical microscopy and transmission electron microscopy (TEM) are used to confirm the in vitro targeted nuclear delivery of peptide-conjugated biocompatible Au NPs by showing their presence in the cancer cell nucleus.

Citation Download Citation

Wei Qian, Taeyjuana Curry, Yong Che, and Raoul Kopelman "Targeted delivery of peptide-conjugated biocompatible gold nanoparticles into cancer cell nucleus", Proc. SPIE 8595, Colloidal Nanocrystals for Biomedical Applications VIII, 85951D (22 February 2013); https://doi.org/10.1117/12.2005328

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available